Annual Net Income
-$26.48 M
+$19.35 M+42.22%
December 1, 2022
Summary
- As of February 10, 2025, DMK annual net profit is -$26.48 million, with the most recent change of +$19.35 million (+42.22%) on December 1, 2022.
- During the last 3 years, DMK annual net income has risen by +$1.03 million (+3.76%).
Performance
DMK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Income
-$1.39 M
+$7.19 M+83.81%
September 1, 2023
Summary
- As of February 10, 2025, DMK quarterly net profit is -$1.39 million, with the most recent change of +$7.19 million (+83.81%) on September 1, 2023.
- Over the past year, DMK quarterly net income has increased by +$3.01 million (+68.45%).
Performance
DMK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
-$22.23 M
+$3.01 M+11.93%
September 1, 2023
Summary
- As of February 10, 2025, DMK TTM net profit is -$22.23 million, with the most recent change of +$3.01 million (+11.93%) on September 1, 2023.
- Over the past year, DMK TTM net income has increased by +$9.69 million (+30.36%).
Performance
DMK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
DMK Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +42.2% | +68.5% | +30.4% |
3 y3 years | +3.8% | +87.8% | +37.2% |
5 y5 years | -3.7% | +84.4% | +19.2% |
DMK Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +73.1% | at high | +646.0% | at high | +106.1% |
5 y | 5-year | at high | +86.5% | at high | +1186.7% | at high | +158.7% |
alltime | all time | -373.8% | +86.5% | -109.3% | +1286.5% | -262.9% | +158.7% |
DMK Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | - | -$1.39 M(-83.8%) | -$22.23 M(-11.9%) |
Jun 2023 | - | -$8.57 M(-4.1%) | -$25.24 M(+0.7%) |
Mar 2023 | - | -$8.94 M(+168.8%) | -$25.07 M(-5.3%) |
Dec 2022 | -$26.48 M(-42.2%) | -$3.33 M(-24.4%) | -$26.48 M(-17.1%) |
Sep 2022 | - | -$4.40 M(-47.6%) | -$31.92 M(-20.0%) |
Jun 2022 | - | -$8.40 M(-18.9%) | -$39.89 M(-2.2%) |
Mar 2022 | - | -$10.35 M(+18.0%) | -$40.80 M(-11.0%) |
Dec 2021 | -$45.83 M(-7.2%) | -$8.77 M(-29.0%) | -$45.83 M(-16.5%) |
Sep 2021 | - | -$12.36 M(+32.7%) | -$54.91 M(+1.9%) |
Jun 2021 | - | -$9.31 M(-39.4%) | -$53.91 M(-6.3%) |
Mar 2021 | - | -$15.38 M(-13.9%) | -$57.52 M(+16.5%) |
Dec 2020 | -$49.39 M(+79.5%) | -$17.86 M(+57.2%) | -$49.39 M(+39.4%) |
Sep 2020 | - | -$11.36 M(-12.1%) | -$35.42 M(+14.0%) |
Jun 2020 | - | -$12.92 M(+78.4%) | -$31.06 M(+20.1%) |
Mar 2020 | - | -$7.25 M(+86.3%) | -$25.87 M(-6.0%) |
Dec 2019 | -$27.51 M(-29.5%) | -$3.89 M(-44.4%) | -$27.51 M(-24.5%) |
Sep 2019 | - | -$7.00 M(-9.5%) | -$36.43 M(-4.9%) |
Jun 2019 | - | -$7.74 M(-13.0%) | -$38.31 M(-4.9%) |
Mar 2019 | - | -$8.89 M(-30.6%) | -$40.28 M(+3.3%) |
Dec 2018 | -$39.01 M(+52.7%) | -$12.81 M(+44.3%) | -$39.01 M(+14.0%) |
Sep 2018 | - | -$8.88 M(-8.5%) | -$34.22 M(+6.6%) |
Jun 2018 | - | -$9.70 M(+27.4%) | -$32.12 M(+17.3%) |
Mar 2018 | - | -$7.62 M(-5.1%) | -$27.38 M(+7.2%) |
Dec 2017 | -$25.54 M(+31.4%) | -$8.03 M(+18.6%) | -$25.54 M(+40.5%) |
Sep 2017 | - | -$6.77 M(+36.2%) | -$18.18 M(+0.7%) |
Jun 2017 | - | -$4.97 M(-13.9%) | -$18.06 M(-4.0%) |
Mar 2017 | - | -$5.77 M(+761.4%) | -$18.80 M(-3.3%) |
Dec 2016 | -$19.44 M(+43.2%) | -$670.20 K(-89.9%) | -$19.44 M(-13.2%) |
Sep 2016 | - | -$6.64 M(+16.3%) | -$22.40 M(+18.5%) |
Jun 2016 | - | -$5.71 M(-10.8%) | -$18.91 M(+12.3%) |
Mar 2016 | - | -$6.41 M(+76.2%) | -$16.84 M(+24.1%) |
Dec 2015 | -$13.57 M(+45.7%) | -$3.64 M(+15.5%) | -$13.57 M(+36.6%) |
Sep 2015 | - | -$3.15 M(-13.6%) | -$9.93 M(+11.5%) |
Jun 2015 | - | -$3.64 M(+16.0%) | -$8.91 M(+9.4%) |
Mar 2015 | - | -$3.14 M(+47.9%) | -$8.15 M(-32.6%) |
Dec 2014 | -$9.32 M(+14.2%) | - | - |
Sep 2014 | - | -$2.12 M(-26.3%) | -$12.09 M(+20.9%) |
Jun 2014 | - | -$2.88 M(+85.6%) | -$9.99 M(+22.5%) |
Mar 2014 | -$8.16 M(+13.4%) | -$1.55 M(-71.9%) | -$8.16 M(-1.0%) |
Dec 2013 | - | -$5.53 M(>+9900.0%) | -$8.24 M(+75.9%) |
Sep 2013 | - | -$32.00 K(-96.9%) | -$4.69 M(-15.0%) |
Jun 2013 | - | -$1.04 M(-36.3%) | -$5.51 M(-23.4%) |
Mar 2013 | -$7.19 M(+46.4%) | -$1.64 M(-17.1%) | -$7.19 M(+6.4%) |
Dec 2012 | - | -$1.97 M(+130.2%) | -$6.76 M(+17.0%) |
Sep 2012 | - | -$857.50 K(-68.5%) | -$5.78 M(-9.7%) |
Jun 2012 | - | -$2.73 M(+126.1%) | -$6.40 M(+30.2%) |
Mar 2012 | -$4.92 M(-29.6%) | -$1.21 M(+21.7%) | -$4.92 M(+1.2%) |
Dec 2011 | - | -$991.30 K(-32.9%) | -$4.86 M(-30.2%) |
Sep 2011 | - | -$1.48 M(+19.1%) | -$6.96 M(+0.8%) |
Jun 2011 | - | -$1.24 M(+7.9%) | -$6.91 M(-1.0%) |
Mar 2011 | -$6.98 M(+4.1%) | -$1.15 M(-62.8%) | -$6.98 M(-32.6%) |
Dec 2010 | - | -$3.09 M(+117.0%) | -$10.36 M(+26.1%) |
Sep 2010 | - | -$1.43 M(+8.7%) | -$8.22 M(+12.1%) |
Jun 2010 | - | -$1.31 M(-71.0%) | -$7.33 M(+9.3%) |
Mar 2010 | -$6.71 M | -$4.53 M(+376.8%) | -$6.71 M(+169.9%) |
Dec 2009 | - | -$949.80 K(+75.9%) | -$2.49 M(+33.6%) |
Sep 2009 | - | -$540.10 K(-21.6%) | -$1.86 M(+13.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2009 | - | -$688.50 K(+124.3%) | -$1.64 M(+22.3%) |
Mar 2009 | - | -$307.00 K(-5.5%) | -$1.34 M(-12.5%) |
Dec 2008 | -$1.53 M(-20.4%) | -$324.90 K(+1.2%) | -$1.53 M(-15.3%) |
Sep 2008 | - | -$321.00 K(-17.5%) | -$1.81 M(0.0%) |
Jun 2008 | - | -$389.00 K(-21.9%) | -$1.81 M(-4.1%) |
Mar 2008 | - | -$498.00 K(-17.3%) | -$1.89 M(-2.0%) |
Dec 2007 | -$1.93 M(-119.9%) | -$602.10 K(+87.6%) | -$1.93 M(-114.1%) |
Sep 2007 | - | -$321.00 K(-31.1%) | $13.65 M(+10.7%) |
Jun 2007 | - | -$466.00 K(-13.2%) | $12.33 M(+6.8%) |
Mar 2007 | - | -$537.00 K(-103.6%) | $11.54 M(+18.6%) |
Dec 2006 | $9.67 M(-293.1%) | $14.97 M(-1013.0%) | $9.73 M(-235.1%) |
Sep 2006 | - | -$1.64 M(+31.1%) | -$7.20 M(-13.8%) |
Jun 2006 | - | -$1.25 M(-46.8%) | -$8.36 M(+267.9%) |
Mar 2006 | - | -$2.35 M(+19.8%) | -$2.27 M(-54.6%) |
Dec 2005 | -$5.01 M(-82.2%) | -$1.96 M(-29.7%) | -$5.01 M(-77.5%) |
Sep 2005 | - | -$2.79 M(-157.8%) | -$22.29 M(-1.5%) |
Jun 2005 | - | $4.83 M(-195.1%) | -$22.64 M(-25.0%) |
Mar 2005 | - | -$5.09 M(-73.6%) | -$30.18 M(+7.2%) |
Dec 2004 | -$28.15 M(+108.0%) | -$19.25 M(+512.3%) | -$28.15 M(+125.3%) |
Sep 2004 | - | -$3.14 M(+16.1%) | -$12.49 M(+3.9%) |
Jun 2004 | - | -$2.71 M(-11.4%) | -$12.02 M(-13.5%) |
Mar 2004 | - | -$3.06 M(-14.7%) | -$13.89 M(-0.5%) |
Dec 2003 | -$13.53 M(-15.1%) | -$3.58 M(+34.3%) | -$13.97 M(-4.9%) |
Sep 2003 | - | -$2.67 M(-41.7%) | -$14.69 M(+7.7%) |
Jun 2003 | - | -$4.58 M(+46.3%) | -$13.64 M(-7.1%) |
Mar 2003 | - | -$3.13 M(-27.2%) | -$14.68 M(-7.9%) |
Dec 2002 | -$15.94 M(-18.1%) | -$4.30 M(+165.1%) | -$15.94 M(-17.4%) |
Sep 2002 | - | -$1.62 M(-71.1%) | -$19.29 M(-10.4%) |
Jun 2002 | - | -$5.62 M(+28.2%) | -$21.54 M(+7.3%) |
Mar 2002 | - | -$4.39 M(-42.7%) | -$20.07 M(+3.1%) |
Dec 2001 | -$19.46 M(+70.5%) | -$7.66 M(+97.9%) | -$19.46 M(+25.1%) |
Sep 2001 | - | -$3.87 M(-6.9%) | -$15.56 M(+5.5%) |
Jun 2001 | - | -$4.16 M(+10.0%) | -$14.75 M(+11.0%) |
Mar 2001 | - | -$3.78 M(+0.6%) | -$13.28 M(+16.3%) |
Dec 2000 | -$11.42 M(+22.8%) | -$3.75 M(+22.7%) | -$11.42 M(+13.4%) |
Sep 2000 | - | -$3.06 M(+13.7%) | -$10.07 M(+13.0%) |
Jun 2000 | - | -$2.69 M(+40.5%) | -$8.91 M(+4.8%) |
Mar 2000 | - | -$1.92 M(-20.2%) | -$8.50 M(-8.5%) |
Dec 1999 | -$9.30 M(+26.3%) | -$2.40 M(+26.4%) | -$9.28 M(+6.1%) |
Sep 1999 | - | -$1.90 M(-16.7%) | -$8.75 M(-1.1%) |
Jun 1999 | - | -$2.28 M(-15.6%) | -$8.85 M(+0.9%) |
Mar 1999 | - | -$2.70 M(+44.7%) | -$8.77 M(+19.0%) |
Dec 1998 | -$7.37 M(-6.8%) | -$1.87 M(-6.7%) | -$7.37 M(-32.4%) |
Sep 1998 | - | -$2.00 M(-9.1%) | -$10.90 M(+13.5%) |
Jun 1998 | - | -$2.20 M(+69.2%) | -$9.60 M(+15.7%) |
Mar 1998 | - | -$1.30 M(-75.9%) | -$8.30 M(+5.1%) |
Dec 1997 | -$7.90 M(+132.4%) | -$5.40 M(+671.4%) | -$7.90 M(+154.8%) |
Sep 1997 | - | -$700.00 K(-22.2%) | -$3.10 M(-6.1%) |
Jun 1997 | - | -$900.00 K(0.0%) | -$3.30 M(-2.9%) |
Mar 1997 | - | -$900.00 K(+50.0%) | -$3.40 M(0.0%) |
Dec 1996 | -$3.40 M(+54.5%) | -$600.00 K(-33.3%) | -$3.40 M(-10.5%) |
Sep 1996 | - | -$900.00 K(-10.0%) | -$3.80 M(0.0%) |
Jun 1996 | - | -$1.00 M(+11.1%) | -$3.80 M(+52.0%) |
Mar 1996 | - | -$900.00 K(-10.0%) | -$2.50 M(+8.7%) |
Dec 1995 | -$2.20 M | -$1.00 M(+11.1%) | -$2.30 M(+76.9%) |
Sep 1995 | - | -$900.00 K(-400.0%) | -$1.30 M(+225.0%) |
Jun 1995 | - | $300.00 K(-142.9%) | -$400.00 K(-42.9%) |
Mar 1995 | - | -$700.00 K | -$700.00 K |
FAQ
- What is DMK Pharmaceuticals annual net profit?
- What is the all time high annual net income for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals annual net income year-on-year change?
- What is DMK Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals quarterly net income year-on-year change?
- What is DMK Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals TTM net income year-on-year change?
What is DMK Pharmaceuticals annual net profit?
The current annual net income of DMK is -$26.48 M
What is the all time high annual net income for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high annual net profit is $9.67 M
What is DMK Pharmaceuticals annual net income year-on-year change?
Over the past year, DMK annual net profit has changed by +$19.35 M (+42.22%)
What is DMK Pharmaceuticals quarterly net profit?
The current quarterly net income of DMK is -$1.39 M
What is the all time high quarterly net income for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high quarterly net profit is $14.97 M
What is DMK Pharmaceuticals quarterly net income year-on-year change?
Over the past year, DMK quarterly net profit has changed by +$3.01 M (+68.45%)
What is DMK Pharmaceuticals TTM net profit?
The current TTM net income of DMK is -$22.23 M
What is the all time high TTM net income for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high TTM net profit is $13.65 M
What is DMK Pharmaceuticals TTM net income year-on-year change?
Over the past year, DMK TTM net profit has changed by +$9.69 M (+30.36%)